Who Owns PRLD?

Prelude Therapeutics Incorporated — Institutional Ownership & 13F Holdings

$4.29

-0.23 (-5.20%)

Market Cap

$170.5M

Shares Outstanding

76,835,443

Institutional Holders

57

Total Inst. Value

$26.9M

% of Float Held

QoQ Holder Change

+4

Institutional data as of Q1 2025

New Positions

4

Closed Positions

8

Increased

18

Decreased

24

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1ORBIMED ADVISORS LLC$8.4M10,909,256
2BAKER BROS. ADVISORS LP$7.8M10,123,824
3Nuveen, LLCNew$3.6M187,613
4Boxer Capital Management, LLC$1.6M2,108,014
5BlackRock, Inc.$805K1,047,725
6VANGUARD GROUP INC$773K1,009,204
7PRICE T ROWE ASSOCIATES INC /MD/$750K976,147
8RENAISSANCE TECHNOLOGIES LLC$504K656,700
9ACADIAN ASSET MANAGEMENT LLC$405K529,327
10GEODE CAPITAL MANAGEMENT, LLC$310K404,955

Biggest Buyers & Sellers This Quarter

Top Sellers

Famous Fund Managers

Related Stocks

Frequently Asked Questions

How many institutional investors hold PRLD?

As of Q1 2025, 57 institutional investors report holding PRLD (Prelude Therapeutics Incorporated) in their 13F filings.

Which hedge fund owns the most PRLD?

The largest institutional holder of PRLD is ORBIMED ADVISORS LLC with $8.4M in shares.

Are institutions buying or selling PRLD?

This quarter, 4 institutions opened new positions in PRLD and 8 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.